Characterization of cancer omics and drug perturbations in panels of lung cancer cells

Ítems similars

• Identification of potential regulatory mutations using multi-omics analysis and haplotyping of lung adenocarcinoma cell lines
  per: Sereewattanawoot, Sarun, et al.
  Publicat: (2018)
• Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines
  per: Suzuki, Ayako, et al.
  Publicat: (2014)
• Sequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer
  per: Suzuki, Ayako, et al.
  Publicat: (2017)
• Identification and Characterization of Cancer Mutations in Japanese Lung Adenocarcinoma without Sequencing of Normal Tissue Counterparts
  per: Suzuki, Ayako, et al.
  Publicat: (2013)
• Genome-wide identification and annotation of HIF-1α binding sites in two cell lines using massively parallel sequencing
  per: Tanimoto, Kousuke, et al.
  Publicat: (2011)